Genezen Appoints CEO

Ray Kaczmarek

Listen to this story

Subscriber Benefit

As a subscriber you can listen to articles at work, in the car, or while you work out. Subscribe Now

This audio file is brought to you by

0:00

0:00

Loading audio file, please wait.

Speed
1.00

• 0.25
• 0.50
• 0.75
• 1.00
• 1.25
• 1.50
• 1.75
• 2.00

Genezen Inc., a cell and gene therapy Contract Development and Manufacturing Organization, has appointed Ray Kaczmarek chief executive officer. He has more than 28 years of leadership experience with the past 20 years in pharmaceutical and biotechnology manufacturing and supply chain operations. 

The past seven years, Kaczmarek has served in various roles at the executive level with the most recent roles being SVP of GMP Operations at TriLink Biotechnologies, president at Nitto Avecia Pharma Services, and vice president manufacturing and supply chain operations for Pacira Biosciences.

His appointment comes at a time of major advancement for the Indianapolis-based organization. With a unique knowledge and expertise in lentiviral and retroviral vectors, Genezen specializes in early-phase process development, vector production, cell manufacturing, and analytical testing services.